'The dark before the dawn': the 2021 British Thoracic Society Audit of the treatment of tobacco dependency in acute trusts.


Journal

BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 02 11 2022
accepted: 08 09 2023
medline: 1 12 2023
pubmed: 30 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Smoking remains the single largest cause of preventable death, disability and health inequality. Smoking tobacco directly contributes to over 500 000 hospital admissions each year, making hospitals an important location to optimise treatment for tobacco dependency. The third British Thoracic Society Tobacco Dependency Audit was undertaken to determine how effectively national standards for treating tobacco-dependent smokers have been implemented and assess if any progress has been made from previous audits. Data on 14579 patients from 119 hospitals revealed 21% of patients were current smokers, 45% were offered very brief advice and 5% prescribed combination nicotine replacement therapy or varenicline. Only 9% completed a consultation with a specialist tobacco dependency practitioner during their inpatient stay and fewer than 1% of smokers were abstinent at 4 weeks following discharge. Clinical leadership of tobacco dependency services was deficient, and staff were ill equipped in supporting current smokers in their efforts to quit with only 50% of trusts offering regular smoking cessation training. There has been little meaningful improvement from previous audits and there remains woefully inadequate provision of tobacco dependency treatment for patients who smoke. The National Health Service (NHS) Long Term Plan has committed substantial, new funding to the NHS to ensure every patient that smokes admitted to hospital will be offered evidence-based support and treatment for tobacco dependency. The findings of this audit highlight the urgency with which this programme must be implemented to tackle the greatest cause of premature death in the UK and to achieve the wider well-recognised benefits for the healthcare system.

Identifiants

pubmed: 38030263
pii: 10/1/e001532
doi: 10.1136/bmjresp-2022-001532
pmc: PMC10689366
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ. 2013 Jul 08;347:f4004
pubmed: 23836616
Tob Control. 2017 May;26(3):293-299
pubmed: 27225016
Clin Med (Lond). 2020 Mar;20(2):196-202
pubmed: 32188658
Cochrane Database Syst Rev. 2022 Nov 17;11:CD010216
pubmed: 36384212

Auteurs

Nikesh Devani (N)

Department of Respiratory Medicine, Royal Free London NHS Foundation Trust, London, UK nikesh.devani@nhs.net.

Zaheer Mangera (Z)

Department of Respiratory Medicine, North Middlesex University Hospital NHS Trust, London, UK.

Howard Smith (H)

Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.

Jessica Gates (J)

Department of Respiratory Medicine, Kingston Hospital NHS Foundation Trust, London, UK.

Arran Woodhouse (A)

Tobacco Dependence Team, King's College Hospital NHS Foundation Trust, London, UK.

Duncan Fullerton (D)

Respiratory Department, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK.

Aravind Ponnuswamy (A)

Department of Respiratory Medicine, Countess of Chester Hospital NHS FT, Chester, UK.

Matthew Evison (M)

Lung Cancer and Thoracic Surgery Directorate, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH